logo
ResearchBunny Logo
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages

Medicine and Health

Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages

M. Chernychev, M. Sakharkar, et al.

This groundbreaking study reveals how vaccination of individuals previously infected with SARS-CoV-2 leads to intense and diverse antibody responses. Researchers isolated 459 spike-specific monoclonal antibodies, demonstrating their neutralizing ability against various viral variants, proving the efficacy of mRNA vaccines in enhancing immune response among convalescent individuals. Conducted by Mark Chernychev and colleagues.

00:00
00:00
~3 min • Beginner • English
Abstract
Vaccination of SARS-CoV-2 convalescent individuals generates broad and potent antibody responses. Here, we isolate 459 spike-specific monoclonal antibodies (mAbs) from two individuals who were infected with the index variant of SARS-CoV-2 and later boosted with mRNA-1273. We characterize mAb genetic features by sequence assignments to the donors' personal immunoglobulin genotypes and assess antibody neutralizing activities against index SARS-CoV-2, Beta, Delta, and Omicron variants. The mAbs used a broad range of immunoglobulin heavy chain (IGH) V genes in the response to all subdomains of the spike examined, with similar characteristics observed in both donors. IGH repertoire sequencing and B cell lineage tracing at long-term time points reveals extensive evolution of SARS-CoV-2 spike-binding antibodies from acute infection until vaccination five months later. These results demonstrate that highly polyclonal repertoires of affinity-matured memory B cells are efficiently recalled by vaccination, providing a basis for potent antibody responses observed in convalescent persons following vaccination.
Publisher
Nature Communications
Published On
Apr 19, 2023
Authors
Mark Chernychev, Mrunal Sakharkar, Ruth I. Connor, Haley L. Dugan, Daniel J. Sheward, C. G. Rappazzo, Aron Ståhlmarck, Mattias N. E. Forsell, Peter F. Wright, Martin Corcoran, Ben Murrell, Laura M. Walker, Gunilla B. Karlsson Hedestam
Tags
SARS-CoV-2
vaccination
antibody responses
spike-specific monoclonal antibodies
neutralizing activity
memory B cells
mRNA-1273
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny